Aurobindo gets USFDA nod to market generic Osteoporosis drug
Aurobindo Pharma today said it has received final approval from USFDA to manufacture and market generic version of Risedronate Sodium tablets, used in the treatment of Osteoporosis, in the American market.
Dec 01, 2015, 20:42 PM IST